← All stocks

VERACYTE, INC.

VCYT Net selling
CIK 0001384101 #1647 in the set updated 17 Sep 2026
Bought (120 mo)
$1.05M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$274.05M
$16.85M on a plan · $70.01M straight out of an exercise
Sold at will
$187.20M
77 of 353 sales
Net
−$273.00M
−$186.15M against sales at will

By person

30 insiders · 382 transactions
25.2×

Marc Stapley holds 25.2 times base salary in stock. $17.69M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $40.95, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EASTHAM KARIN
Director
$149.91M (30)
−$149.91M
19,497
0.0243%
$798.39K
+10.6%
TREU JESSE I
Director
$26.86M (13)
−$26.86M
1,236,571
1.54%
$50.64M
−56.0%
Anderson Bonnie H
Director
$26.05M (66) scheduled
−$26.05M
396,606
0.4933%
$16.24M
+69.7%
JONES EVAN/ FA
Director
$12.28M (53)
−$12.28M
104,287
0.1297%
$4.27M
−75.1%
Kennedy Giulia C
Chief Scientific & Med Officer
$12.22M (53) scheduled
−$12.22M
65,970
0.0821%
$2.70M
+601.3%
Stapley Marc
Chief Executive Officer
$980.09K (1)
$11.15M (11) scheduled
−$10.17M
432,073
0.5375%
$17.69M
+7,904%
Hall Christopher M
President and COO
$6.66M (15) scheduled
−$6.66M
28,258
0.0352%
$1.16M
Hanna John Walter JR
Chief Commercial Officer
$6.47M (19) scheduled
−$6.47M
73,844
0.0919%
$3.02M
+10.3%
Kennedy Keith
COO / CFO
$4.22M (8) scheduled
−$4.22M
116,858
0.1454%
$4.79M
+1,131%
Chambers Rebecca
Chief Financial Officer
$2.82M (12) scheduled
−$2.82M
166,025
0.2065%
$6.80M
+9,113%
McGuire Annie
EVP, General Counsel
$2.74M (17) scheduled
−$2.74M
131,160
0.1632%
$5.37M
+8,535%
EPSTEIN ROBERT S
Director
$2.07M (6) scheduled
−$2.07M
57,718
0.0718%
$2.36M
Leite John
Global Chief Commercial Off
$1.92M (12) scheduled
−$1.92M
128,344
0.1597%
$5.26M
+209.5%
Wygant Jonathan
VP, Chief Accounting Officer
$1.80M (5) scheduled
−$1.80M
43,226
0.0538%
$1.77M
+174.5%
Febbo Phillip G.
Chief Scientific & Med Officer
$1.79M (7) scheduled
−$1.79M
133,048
0.1655%
$5.45M
GORDON KEVIN K
Director
$1.24M (5) scheduled
−$1.24M
8,720
0.0108%
$357.08K
Cohen Fred E
Director
$1.07M (2)
−$1.07M
10,000
0.0124%
$409.49K
Holstein Jens
Director
$70.39K (1)
$1.04M (9) scheduled
−$967.27K
27,471
0.0342%
$1.12M
Ho Mark
Principal Accounting Officer
$624.38K (1)
−$624.38K
71,728
0.0892%
$2.94M
+199.3%
BISHOP JOHN L
Director
$605.00K (2) scheduled
−$605.00K
33,125
0.0412%
$1.36M
Bhanji Muna
Director
$509.08K (7) scheduled
−$509.08K
42,718
0.0531%
$1.75M
KLEINER PERKINS CAUFIELD & BYERS XII, LLC entity
10% owner
2,801,929
3.49%
$114.74M
−21.1%
Nova Tina Susan
President, CLIA U.S.
76,988
0.0958%
$3.15M
+147.3%
Barr Eliav
Director
56,461
0.0702%
$2.31M
Haas Kevin Richard
Chief Dev and Tech Officer
44,221
0.0550%
$1.81M
Shafer David Brent
Director
31,100
0.0387%
$1.27M
Miller Thomas F.
Director
31,100
0.0387%
$1.27M
Alley Beverly Jane
VP, Corporate Controller
13,000
0.0162%
$532.34K
+73.3%
Erlinger III James H
EVP, General Counsel
7,500
0.0093%
$307.12K
Brooks Julie
EVP, Gen Counsel and Secretary
4,162
0.0052%
$170.43K
+10.0%
Insider
Date
Role
Action
Shares
Price
Amount
Holstein Jens
14 Sep 2026
Director
Sold on a plan
5,000
$40.95
$204.75K
McGuire Annie
4 Sep 2026
EVP, General Counsel
Sold on a plan
1,100
$43.67
$48.04K
McGuire Annie
4 Sep 2026
EVP, General Counsel
Sold on a plan
2,154
$42.79
$92.17K
Chambers Rebecca
4 Sep 2026
Chief Financial Officer
Sold on a plan
1,175
$43.71
$51.36K
Chambers Rebecca
4 Sep 2026
Chief Financial Officer
Sold on a plan
2,477
$42.81
$106.03K
Febbo Phillip G.
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
2,705
$43.66
$118.11K
Febbo Phillip G.
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
10,405
$42.89
$446.30K
Bhanji Muna
1 Sep 2026
Director
Sold on a plan
1,864
$42.97
$80.10K
EASTHAM KARIN
18 Jun 2026
Director
Sold on a plan
529
$53.55
$28.33K
EASTHAM KARIN
18 Jun 2026
Director
Sold on a plan
3,200
$52.78
$168.91K
Leite John
4 Jun 2026
Global Chief Commercial Off
Sold on a plan
13,975
$50.07
$699.73K
Chambers Rebecca
4 Jun 2026
Chief Financial Officer
Sold on a plan
1,961
$50.09
$98.23K
Chambers Rebecca
4 Jun 2026
Chief Financial Officer
Sold on a plan
1,600
$49.28
$78.85K
McGuire Annie
4 Jun 2026
EVP, General Counsel
Sold on a plan
1,776
$50.12
$89.01K
McGuire Annie
4 Jun 2026
EVP, General Counsel
Sold on a plan
1,400
$49.31
$69.03K
EPSTEIN ROBERT S
20 May 2026
Director
Sold on a plan
10,000
$44.01
$440.13K
McGuire Annie
6 May 2026
SVP, General Counsel
Sold on a plan
5,102
$40.00
$204.08K
McGuire Annie
6 May 2026
SVP, General Counsel
Sold on a plan
5,102
$38.05
$194.13K
McGuire Annie
4 Mar 2026
SVP, General Counsel
Sold on a plan
1,664
$36.34
$60.47K
McGuire Annie
4 Mar 2026
SVP, General Counsel
Sold on a plan
4,994
$35.29
$176.26K
Leite John
4 Mar 2026
Chief Commercial Officer-CLIA
Sold on a plan
5,260
$35.19
$185.08K
Stapley Marc
4 Mar 2026
Chief Executive Officer
Sold on a plan
26,279
$36.28
$953.37K
Stapley Marc
4 Mar 2026
Chief Executive Officer
Sold on a plan
19,244
$35.56
$684.23K
Chambers Rebecca
4 Mar 2026
Chief Financial Officer
Sold on a plan
13,941
$36.33
$506.46K
Chambers Rebecca
4 Mar 2026
Chief Financial Officer
Sold on a plan
4,400
$35.55
$156.41K
Febbo Phillip G.
2 Mar 2026
Chief Scientific & Med Officer
Sold on a plan
13,425
$36.16
$485.43K
McGuire Annie
16 Dec 2025
SVP, General Counsel
Sold on a plan
100
$43.68
$4.37K
McGuire Annie
16 Dec 2025
SVP, General Counsel
Sold on a plan
10,639
$43.13
$458.84K
Leite John
4 Dec 2025
Chief Commercial Officer-CLIA
Sold on a plan
1,278
$47.51
$60.72K
Stapley Marc
4 Dec 2025
Chief Executive Officer
Sold on a plan
3,220
$47.35
$152.46K
Stapley Marc
4 Dec 2025
Chief Executive Officer
Sold on a plan
4,448
$46.90
$208.61K
Chambers Rebecca
4 Dec 2025
Chief Financial Officer
Sold on a plan
4,741
$47.25
$224.01K
Chambers Rebecca
4 Dec 2025
Chief Financial Officer
Sold on a plan
8,537
$46.61
$397.95K
McGuire Annie
4 Dec 2025
SVP, General Counsel
Sold on a plan
702
$47.51
$33.35K
McGuire Annie
4 Dec 2025
SVP, General Counsel
Sold on a plan
720
$47.10
$33.91K
JONES EVAN/ FA
25 Nov 2025
Director
Sold on a plan
1,106
$50.25
$55.58K
Leite John
25 Nov 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,808
$50.00
$140.40K
Holstein Jens
20 Nov 2025
Director
Sold on a plan
1,460
$43.21
$63.09K
Holstein Jens
20 Nov 2025
Director
Sold on a plan
7,049
$42.48
$299.42K
Holstein Jens
20 Nov 2025
Director
Sold on a plan
1,491
$40.95
$61.06K
Chambers Rebecca
5 Nov 2025
Chief Financial Officer
Sold on a plan
7,000
$41.00
$287.00K
EASTHAM KARIN
5 Nov 2025
Director
Sold on a plan
9,674
$40.02
$387.19K
McGuire Annie
5 Nov 2025
SVP, General Counsel
Sold on a plan
6,466
$40.00
$258.64K
Febbo Phillip G.
6 Oct 2025
Chief Scientific & Med Officer
Sold on a plan
8,349
$36.02
$300.71K
McGuire Annie
1 Oct 2025
SVP, General Counsel
Sold on a plan
2,160
$35.00
$75.61K
Leite John
1 Oct 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,539
$35.00
$88.87K
McGuire Annie
19 Sep 2025
SVP, General Counsel
Sold on a plan
2,283
$33.69
$76.92K
Stapley Marc
4 Sep 2025
Chief Executive Officer
Sold on a plan
7,667
$30.41
$233.13K
Bhanji Muna
13 Jun 2025
Director
Sold on a plan
4,589
$26.67
$122.37K
EASTHAM KARIN
13 Jun 2025
Director
Sold on a plan
4,590
$26.66
$122.39K
Leite John
4 Jun 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,809
$27.20
$76.41K
Leite John
7 Mar 2025
Chief Commercial Officer-CLIA
Sold on a plan
5,011
$31.96
$160.15K
Leite John
7 Mar 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,400
$31.04
$74.48K
McGuire Annie
4 Mar 2025
SVP, General Counsel
Sold on a plan
1,142
$33.69
$38.48K
Stapley Marc
4 Mar 2025
Chief Executive Officer
Sold on a plan
1,094
$34.37
$37.60K
Stapley Marc
4 Mar 2025
Chief Executive Officer
Sold on a plan
23,414
$33.91
$794.01K
Stapley Marc
4 Mar 2025
Chief Executive Officer
Sold on a plan
28,189
$32.82
$925.25K
Febbo Phillip G.
4 Mar 2025
Chief Scientific & Med Officer
Sold on a plan
3,570
$33.95
$121.21K
Febbo Phillip G.
4 Mar 2025
Chief Scientific & Med Officer
Sold on a plan
4,467
$32.86
$146.81K
Chambers Rebecca
3 Feb 2025
Chief Financial Officer
Sold on a plan
527
$43.85
$23.11K
Stapley Marc
13 Dec 2024
Chief Executive Officer
Sold on a plan
400
$44.14
$17.66K
Stapley Marc
13 Dec 2024
Chief Executive Officer
Sold on a plan
5,190
$43.37
$225.08K
McGuire Annie
4 Dec 2024
SVP, General Counsel
Sold on a plan
18,699
$44.02
$823.18K
Febbo Phillip G.
4 Dec 2024
Chief Scientific & Med Officer
Sold on a plan
3,934
$44.09
$173.45K
Chambers Rebecca
3 Dec 2024
Chief Financial Officer
Sold on a plan
7,000
$43.23
$302.62K
EASTHAM KARIN
19 Nov 2024
Director
Sold on a plan
10,125
$38.76
$392.40K
EASTHAM KARIN
19 Nov 2024
Director
Sold on a plan
3,006
$37.77
$113.54K
EASTHAM KARIN
19 Nov 2024
Director
Sold on a plan
1,600
$36.77
$58.83K
Chambers Rebecca
12 Nov 2024
Chief Financial Officer
Sold on a plan
15,275
$38.34
$585.66K
JONES EVAN/ FA
19 Sep 2024
Director
Sold on a plan indirect
5,173
$35.23
$182.26K
Leite John
4 Sep 2024
Chief Commercial Officer-CLIA
Sold on a plan
5,479
$29.78
$163.16K
JONES EVAN/ FA
12 Aug 2024
Director
Sold on a plan indirect
101
$30.01
$3.03K
JONES EVAN/ FA
12 Aug 2024
Director
Sold on a plan
99
$30.01
$2.97K
Holstein Jens
7 Aug 2024
Director
Sold on a plan
2,500
$30.00
$75.00K
Holstein Jens
7 Aug 2024
Director
Sold on a plan
2,500
$28.00
$70.00K
Holstein Jens
16 Jul 2024
Director
Sold on a plan
2,500
$25.00
$62.50K
Holstein Jens
16 Jul 2024
Director
Sold on a plan
2,500
$24.00
$60.00K
Leite John
16 Jul 2024
Chief Commercial Officer-CLIA
Sold on a plan
1,277
$25.00
$31.93K
EASTHAM KARIN
16 Jul 2024
Director
Sold on a plan
7,500
$25.00
$187.50K
EASTHAM KARIN
11 Jun 2024
Director
Sold on a plan
3,870
$20.59
$79.68K
Bhanji Muna
10 Jun 2024
Director
Sold on a plan
3,870
$20.32
$78.63K
Bhanji Muna
28 May 2024
Director
Sold on a plan
1,539
$21.00
$32.32K
Bhanji Muna
16 Jun 2023
Director
Sold on a plan
100
$27.09
$2.71K
Bhanji Muna
16 Jun 2023
Director
Sold on a plan
5,793
$26.42
$153.08K
Showing 250 of 382 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 492
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 84
Sales straight out of an exercise 192
Sales at will 77
Transactions with no price 0
Shares from compensation/vesting 7,377,221
Sales filed before the plan box existed 64
History held since 8 Dec 2016